| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: MimiVax |
| Recipient: You |
| Company: doctible |
| Recipient: You |
| Company: MedInnovate Advisors LLC |
| Recipient: You |
| Company: TriSalus Life Sciences |
| Recipient: You |
|
| Honoraria |
| Company: Prime Oncology |
| Recipient: You |
| Company: Elsevier |
| Recipient: You |
| Company: Prime Education |
| Recipient: You |
| Company: Peerview |
| Recipient: You |
|
| Consulting or Advisory Role |
| Company: InSightec |
| Recipient: You |
| Company: Nuvation Bio |
| Recipient: You |
| Company: Apollomics |
| Recipient: You |
| Company: GlaxoSmithKline |
| Recipient: You |
| Company: Prelude Therapeutics |
| Recipient: You |
| Company: Janssen |
| Recipient: You |
| Company: ViewRay |
| Recipient: You |
| Company: Xoft |
| Recipient: You |
| Company: SDP Oncology |
| Recipient: You |
| Company: Voyager Therapeutics |
| Recipient: You |
| Company: Pyramid Biosciences |
| Recipient: You |
| Company: Caris Life Sciences |
| Recipient: You |
| Company: Anheart Therapeutics |
| Recipient: You |
| Company: Theraguix |
| Recipient: You |
| Company: Cairn Therapeutics |
| Recipient: You |
| Company: Modifi Biosciences |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: Bugworks |
| Recipient: You |
| Company: Menarini Group |
| Recipient: You |
| Company: Siemens Healhineers/Varian Medical Systems |
| Recipient: You |
| Company: Autem Therapeutics |
| Recipient: You |
| Company: AlloVir |
| Recipient: You |
| Company: Equillium |
| Recipient: You |
| Company: Sumitomo Dainippon Pharma Oncology |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Novartis |
| Recipient: Your Institution |
| Company: Novocure |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
| Company: Pharmacyclics |
| Recipient: Your Institution |
| Company: Incyte |
| Recipient: Your Institution |
| Company: Bayer |
| Recipient: Your Institution |
| Company: Bristol-Myers Squibb |
| Recipient: Your Institution |
| Company: Boston Biomedical |
| Recipient: Your Institution |
| Company: MimiVax |
| Recipient: Your Institution |
| Company: Abbvie |
| Recipient: Your Institution |
| Company: Seattle Genetics |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| Company: ResMed |
| Recipient: An Immediate Family Member |
| Company: Idorsia |
| Recipient: An Immediate Family Member |
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|